Genomic Signatures Associated with the Development, Progression, and Outcome of Prostate Cancer

Author： Mendiratta Prateek   Febbo Phillip G.  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.11, Iss.6, 2007-01, pp. : 345-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genomic signatures of breast cancer metastasis

By  

Cytogenetic and Genome Research, Vol. 118, Iss. 2-4, 2007-11 ,pp. : 116-129

Karger

Access to resources Recommend Favorite

Characterization of the roles of suppressor of cytokine signaling‐3 in prostate cancer development and progression

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 2, 2015-06 ,pp. : 106-113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 556-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 4, 2015-08 ,pp. : 517-530

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methylselenocysteine preventing castration‐resistant progression of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 1001-1008

John Wiley & Sons Inc

Access to resources Recommend Favorite